Top Markets
Coin of the day
Chandra Bhagat Pharma Limited Chandra Bhagat Pharma Limited

Chandra Bhagat Pharma Limited

CBPL
Rank in Stocks #35293
Chandra Bhagat Pharma Ltd. specializes in the distribution and... Chandra Bhagat Pharma Ltd. specializes in the distribution and commercialization of a diverse array of pharmaceutical, critical care, and general healthcare solutions. Their extensive product lineup encompasses various pharmaceutical formulations, notably intravenous (IV) and intramuscular (IM) injectable medications, alongside select tablet forms, serving both national and international clientele. Furthermore, the company actively promotes and markets active pharmaceutical ingredients (APIs). Their offerings are designed to address a spectrum of conditions, including rheumatoid and osteo-arthritis, osteoporosis, carpal tunnel syndrome, tendonitis, rotator cuff tears, muscular dystrophy, myasthenia gravis, and lupus erythematosus, among other health issues. Established in 1944 by Chandravadan C. Bhagat, the company's main operations are based in Mumbai, India.
Share Price
$0.55069028
Last synced: 2026-08-14
Market Cap
$4.15M
Change (1 day)
-4.95%
Change (1 year)
-12.17%
Country
IN
Trade Chandra Bhagat Pharma Limited (CBPL)

Category

P/B ratio for Chandra Bhagat Pharma Limited (CBPL)
P/B ratio as of 2026 TTM: 0
According to Chandra Bhagat Pharma Limited latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Chandra Bhagat Pharma Limited from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
-24.3279 -
US
- -
US
-19.2508 -
US
- -
US
5.5898 -
AU